JPI-289 Low-dose: Clinical Trials

1 trial of JPI-289 Low-dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow JPI-289 Low-dose: new trials by email Literature Review of JPI-289 Low-dose trials Research Report on JPI-289 Low-dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Trial to Evaluate the Efficacy and Safety of JPI-289 in Patients With Acute Ischemic Stroke
JPI-289 Low-dose, JPI-289 High-dose, Placebo - Acute Ischemic Stroke
Phase 2UnknownJeil Pharmaceutical Co., Ltd.1102016-12-092019-11-18

Conditions studied

Ischemic Stroke (1)

Sponsors

Jeil Pharmaceutical Co., Ltd. (1)

Countries

South Korea (1)